Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.

Arnsten AF, Scahill L, Findling RL.

J Child Adolesc Psychopharmacol. 2007 Aug;17(4):393-406. Review.

PMID:
17822336
[PubMed - indexed for MEDLINE]
2.

The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.

Sallee FR.

Postgrad Med. 2010 Sep;122(5):78-87. doi: 10.3810/pgm.2010.09.2204. Review.

PMID:
20861591
[PubMed - indexed for MEDLINE]
3.

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder.

Arnsten AF, Steere JC, Hunt RD.

Arch Gen Psychiatry. 1996 May;53(5):448-55. Review.

PMID:
8624188
[PubMed - indexed for MEDLINE]
4.

Mechanism of action of agents used in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychiatry. 2006;67 Suppl 8:32-8. Review.

PMID:
16961428
[PubMed - indexed for MEDLINE]
5.

Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder.

Scahill L, Barloon L, Farkas L.

J Child Adolesc Psychiatr Nurs. 1999 Oct-Dec;12(4):168-73. Review. No abstract available.

PMID:
10876518
[PubMed - indexed for MEDLINE]
6.

Dopamine vs noradrenaline: inverted-U effects and ADHD theories.

Levy F.

Aust N Z J Psychiatry. 2009 Feb;43(2):101-8. doi: 10.1080/00048670802607238. Review.

PMID:
19153917
[PubMed - indexed for MEDLINE]
7.

Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.

Scahill L.

CNS Drugs. 2009;23 Suppl 1:43-9. doi: 10.2165/00023210-200923000-00006. Review.

PMID:
19621977
[PubMed - indexed for MEDLINE]
8.

Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.

Arnsten AF.

J Clin Psychiatry. 2006;67 Suppl 8:7-12. Review.

PMID:
16961424
[PubMed - indexed for MEDLINE]
9.

Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents.

Connor DF, Rubin J.

Drugs Today (Barc). 2010 May;46(5):299-314. doi: 10.1358/dot.2010.46.5.1450095. Review.

PMID:
20517532
[PubMed - indexed for MEDLINE]
10.

The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.

Himpel S, Banaschewski T, Heise CA, Rothenberger A.

Expert Opin Drug Saf. 2005 Mar;4(2):311-21. Review.

PMID:
15794722
[PubMed - indexed for MEDLINE]
11.

Psychopharmacology of ADHD in adolescents.

Greydanus DE, Sloane MA, Rappley MD.

Adolesc Med. 2002 Oct;13(3):599-624. Review.

PMID:
12270803
[PubMed - indexed for MEDLINE]
12.

Non-stimulant treatment of attention-deficit/hyperactivity disorder.

Pliszka SR.

CNS Spectr. 2003 Apr;8(4):253-8. Review.

PMID:
12679740
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
[PubMed - indexed for MEDLINE]
14.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
[PubMed - indexed for MEDLINE]
15.

[Roles of alpha-2 adrenoceptor in prefrontal cortical cognitive functions].

Mao ZM, Li BM, Arnsten AF.

Sheng Li Ke Xue Jin Zhan. 1999 Jan;30(1):17-22. Review. Chinese.

PMID:
12532843
[PubMed - indexed for MEDLINE]
16.

Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

Arnsten AF, Pliszka SR.

Pharmacol Biochem Behav. 2011 Aug;99(2):211-6. doi: 10.1016/j.pbb.2011.01.020. Epub 2011 Feb 2. Review.

PMID:
21295057
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.

Cinnamon Bidwell L, Dew RE, Kollins SH.

Curr Psychiatry Rep. 2010 Oct;12(5):366-73. doi: 10.1007/s11920-010-0136-4. Review.

PMID:
20652773
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Catecholamine influences on dorsolateral prefrontal cortical networks.

Arnsten AF.

Biol Psychiatry. 2011 Jun 15;69(12):e89-99. doi: 10.1016/j.biopsych.2011.01.027. Epub 2011 Apr 13. Review.

PMID:
21489408
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.

Childress AC, Sallee FR.

Drugs Today (Barc). 2012 Mar;48(3):207-17. doi: 10.1358/dot.2012.48.3.1750904. Review.

PMID:
22462040
[PubMed - indexed for MEDLINE]
20.

Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.

Arnsten AF, Jin LE.

Yale J Biol Med. 2012 Mar;85(1):45-58. Epub 2012 Mar 29. Review.

PMID:
22461743
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk